Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bilateral Occlusive Retinal Vasculitis After Faricimab Rechallenge.

JAMA ophthalmology·2026
Same author

Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Light-evoked activity and BDNF regulate mitochondrial dynamics and mitochondrial localized translation in CNS axons.

iScience·2025
Same author

Evidence and Consensus Based Imaging Guidelines in Multiple Evanescent White Dot Syndrome Multimodal imaging in Uveitis (MUV) Taskforce Report 6.

American journal of ophthalmology·2025
Same author

Clearing the AIR: A <i>PRPH2</i> mutation identified in the evaluation of presumed autoimmune retinopathy.

American journal of ophthalmology case reports·2025
Same author

Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyes.

Molecular therapy : the journal of the American Society of Gene Therapy·2024
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K

Cytokines in uveitis.

Jessica E Weinstein1, Kathryn L Pepple

  • 1University of Washington, Department of Ophthalmology, Seattle, Washington, USA.

Current Opinion in Ophthalmology
|March 10, 2018
PubMed
Summary
This summary is machine-generated.

T helper 17 (Th17) cells and their associated cytokines are key drivers of ocular inflammation in autoimmune uveitis. Targeting these cytokines, particularly IL-23, offers a promising therapeutic strategy for patients.

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.1K
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.9K

Related Experiment Videos

Last Updated: Feb 13, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.1K
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.9K

Area of Science:

  • Immunology
  • Ophthalmology

Background:

  • T helper 17 (Th17) cells are increasingly recognized as critical mediators in ocular inflammatory conditions.
  • Cytokines influencing Th17 cell development and function are potential therapeutic targets for immune-mediated uveitis.

Purpose of the Study:

  • To review the role of key cytokines in ocular inflammation and their association with Th17 cells.
  • To highlight recent laboratory and clinical findings on these cytokines in uveitis.

Main Methods:

  • Review of laboratory and clinical studies focusing on cytokines and Th17 cells in uveitis.
  • Analysis of data from animal models (e.g., experimental autoimmune uveitis) and human patient samples (aqueous, vitreous, serum).
  • Utilized techniques such as flow cytometry and multiplex ELISA bead-based assays.

Main Results:

  • Interleukin (IL)-6, IL-10, IL-17, IL-22, IL-23, and tumor necrosis factor-alpha (TNFα) are implicated in uveitis pathogenesis.
  • IL-23 plays a central role in directing the pathogenic function of Th17 cells.
  • Studies in animal models and human samples confirm the contribution of Th17 cells and related cytokines to ocular inflammation.

Conclusions:

  • Th17 cells and their associated cytokines are significant inflammatory mediators in autoimmune uveitis.
  • Ongoing research in animal and human studies is crucial for developing novel cytokine-targeted therapies for uveitis.